| Literature DB >> 26876331 |
P P Mahesh1, R J Retnakumar1, Sathish Mundayoor1.
Abstract
Mycobacterium tuberculosis persists primarily in macrophages after infection and manipulates the host defence pathways in its favour. 2D gel electrophoresis results showed that vimentin, an intermediate filament protein, is downregulated in macrophages infected with live Mycobacterium tuberculosis H37Rv when compared to macrophages infected with heat- killed H37Rv. The downregulation was confirmed by Western blot and quantitative RT-PCR. Besides, the expression of vimentin in avirulent strain, Mycobacterium tuberculosis H37Ra- infected macrophages was similar to the expression in heat-killed H37Rv- infected macrophages. Increased expression of vimentin in H2O2- treated live H37Rv-infected macrophages and decreased expression of vimentin both in NAC and DPI- treated heat-killed H37Rv-infected macrophages showed that vimentin expression is positively regulated by ROS. Ectopic expression of ESAT-6 in macrophages decreased both the level of ROS and the expression of vimentin which implies that Mycobacterium tuberculosis-mediated downregulation of vimentin is at least in part due to the downregulation of ROS by the pathogen. Interestingly, the incubation of macrophages with anti-vimentin antibody increased the ROS production and decreased the survival of H37Rv. In addition, we also showed that the pattern of phosphorylation of vimentin in macrophages by PKA/PKC is different from monocytes, emphasizing a role for vimentin phosphorylation in macrophage differentiation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26876331 PMCID: PMC4753491 DOI: 10.1038/srep21526
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Vimentin is downregulated by live H37Rv.
(a) Macrophage monolayers were infected with live H37Rv and heat-killed H37Rv and uninfected macrophage was set as control. 2DE was done after 24 h post infection and visualized by Coomassie Blue. The arrow points to the spot picked and later identified as vimentin by MALDI-TOF-TOF. The experiment is a representative of 2 independent experiments with similar results. (b) qRT-PCR was done using the RNA isolated from uninfected macrophages and macrophages infected with heat-killed or live M. tuberculosis H37Rv, 12 h after infection and setting GAPDH as reference gene. Expression of vimentin in live H37Rv-infected macrophages is decreased when compared to heat-killed H37Rv-infected macrophages or uninfected macrophages. Values are expressed as mean ± SE, n = 3, *Mean difference is significant at 0.05 level. (c) Macrophage monolayers were infected with live H37Rv, heat-killed H37Rv and H37Ra. After 12 h of infection different samples were processed for Western blotting. β-tubulin was used as loading control. The expression of vimentin is decreased in live H37Rv-infected macrophages when compared to heat-killed H37Rv infected macrophages, H37Ra-infected macrophages and uninfected macrophages. Values are expressed as mean ± SE, n = 3. *Mean difference is significant at 0.05 level.
Figure 2Profile of vimentin in monocytes and macrophages.
(a) Immunofluorescence of vimentin (red) -stained THP1 monocytes and macrophages clearly demonstrating the difference in the distribution between them (b) The left panel shows Western blot of immunoprecipitate from PKA substrate antibody pull down. PKA/PKC phosphorylated molecular size forms of vimentin in monocytes and macrophages demonstrating that phosphorylated proteins around 53 KDa are present only in induced macrophages. The right panel shows Western blots of total vimentin from 2DE experiments showing the presence of both the cluster of spots near to 53 kDa and the 25 kDa form in monocytes as well as in macrophages; the cluster of spots near to 53 kDa in macrophages has shifted left to a more acidic pI compared to monocytes due to phosphorylation.
Figure 3Downregulation of vimentin by Mycobacterium tuberculosis relates to the pathogen’s anti-inflammatory effect on macrophages.
(a) Macrophage monolayers were infected with live H37Rv. Infected macrophages were treated with H2O2 at100 μM and TNFα at10 ng/ml, after 4 h of phagocytosis. Uniinfected macrophages were treated with LPS at1 μg/ml. After 12 h post infection, all the samples were processed for Western blotting and probed with anti-vimentin antibody; β-tubulin was used as loading control. Live mycobacteria reduce vimentin expression and this is restored by H2O2 and TNFα. LPS increases vimentin and is used as a positive control. Values are expressed as mean ± SE, n = 3, *Mean difference is significant at 0.05 level. (b,c) Macrophage monolayers were infected with heat-killed H37Rv. Infected macrophages were treated with NAC at10 mM, PDTC at 50 μM, GÖ6983 at 500 nM and DPI at10 μM, after 4 h of phagocytosis. After 12 h post infection, all the samples were processed for Western blotting and probed with anti-vimentin antibody; β-tubulin was used as loading control. Values are expressed as mean ± SE, n = 3, *Mean difference is significant at 0.05 level. (d) The level of ROS is found to be decreased in live H37Rv-infected macrophages compared to heat-killed H37Rv-infected macrophages after 24 h of infection. Values are expressed as mean ± SE, n = 4 and p = 0.03.
Figure 4ESAT-6 downregulates both the level of ROS and the expression of vimentin.
THP1 cells were transfected with either plasmid containing ESAT-6 or the control plasmid and treated with PMA to form macrophages. (a) The level of ROS measured as DCFDA fluorescence is decreased in ESAT-6 expressing macrophages compared to the control. Values are expressed as mean ± SE, n = 9. *Mean difference is significant at 0.05 level. (b) Expression of vimentin is decreased in ESAT-6 expressing macrophages compared to the control. Values are expressed as mean ± SE, n = 3. *Mean difference is significant at 0.05 level.
Figure 5Treatment of macrophages with anti-vimentin antibody increases ROS level and killing of M. tuberculosis.
Uninfected macrophage monolayers were treated with anti-vimentin antibody or normal IgG and ROS was measured as DCFDA fluorescence. (a) at 6 h; n = 8, p = 0.005 and (b) at 24 h; n = 7, p = 0.004. (c) Macrophage monolayers were infected with H37Rv and treated with anti-vimentin antibody or normal IgG after phagocytosis. After 24 h post infection, the cells were lysed, diluted to 10−2 and plated; n = 8, p = 0.034. Values are expressed as mean ± SE. CFU measurements show that anti-vimentin antibody treatment decreases the number of live H37Rv.
Selected co-regulated genes for vimentin.
| Co-regulated gene | Description (adopted from NCBI Gene) | Number of experiments | Percentage of concordance | Pearson coefficient | Pearson p-value |
|---|---|---|---|---|---|
| Lectin, galactoside- binding, soluble, 1 (LGALS1) | Implicated in cell-cell and cell-matrix interactions, also pro-apoptotic. | 1852 | 88.012 | 0.595 | 5.128e-298 |
| Reticulocalbin 1, EF-hand calcium binding domain (RCN1) | Reticulocalbin 1 is a calcium-binding protein located in the lumen of the ER | 1413 | 80.537 | 0.583 | 1.130e-282 |
| Interferon induced transmembrane protein 3 (IFITM3) | It acts as an effector molecule for interferon-gamma, which is essential for anti-tuberculosis immune response | 1354 | 86.336 | 0.574 | 7.978e-272 |
| Annexin A5 (ANXA5) | Binds cooperatively to phosphatidylserine on apoptotic cell membranes | 1473 | 92.328 | 0.570 | 4.417e-268 |
| Transforming growth factor, beta receptor II (TGFBR2) | A receptor with Ser/Thr kinase activity | 1478 | 85.250 | 0.549 | 2.105e-244 |
| Notch 2 (NOTCH2) | Regulates interactions between physically adjacent cells. | 1402 | 84.094 | 0.539 | 5.106e-234 |
| G protein-coupled receptor 124 (GPR124) | A member of GPCR family | 1178 | 85.653 | 0.525 | 7.926e-220 |
| Kruppel-like factor 2 (lung) (KLF2) | Regulates T-cell trafficking by promoting expression of S1P1 and the CD62L. | 1418 | 81.734 | 0.516 | 4.316e-211 |
| Platelet-derived growth factor receptor, beta polypeptide (PDGFRB) | A cell surface tyrosine kinase receptor | 1509 | 82.571 | 0.486 | 3.984e-184 |
| Transforming growth factor, beta receptor III (TGFBR3) | A membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptors. | 1551 | 80.141 | 0.453 | 1.323e-157 |
| Mannose receptor, C type 2 (MRC2) | Important in extracellular matrix remodelling and in phagocytosis | 1417 | 81.016 | 0.453 | 4.953e-157 |
| Prostaglandin I2 (prostacyclin) synthase (PTGIS) | Associated with inflammation in atherosclerosis | 1500 | 77.466 | 0.446 | 7.145e-152 |
| Chemokine (C-C motif) ligand 2 (CCL2) | This cytokine displays chemotactic activity for monocytes and basophils | 1357 | 78.555 | 0.430 | 3.820e-140 |
| Tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) | This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. | 1131 | 79.929 | 0.389 | 3.161e-113 |
| Fc fragment of IgG, receptor, transporter, alpha (FCGRT) | A receptor that binds the Fc region of monomeric immunoglobulin G. | 1416 | 73.658 | 0.384 | 4.921e-110 |
| Protein kinase C, delta binding protein (PRKCDBP) | A binding protein of the protein kinase C, delta | 1256 | 78.662 | 0.382 | 1.718e-108 |
| Interleukin 6 (IL6) | Causes acute and chronic inflammation | 1079 | 84.059 | 0.369 | 3.657e-101 |
| Complement component 1, s subcomponent (C1S) | A serine protease and constituent of the human complement subcomponent C1 | 1677 | 75.074 | 0.366 | 2.447e-99 |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA) | A member of the NF-kappa-B inhibitor family, which contains multiple ankrin repeat domains. | 1314 | 76.331 | 0.356 | 1.192e-93 |
| Complement component 1, r subcomponent (C1R) | The first protease activated in the classical complement pathway | 1323 | 78.155 | 0.355 | 3.442e-93 |
| Tumor necrosis factor, alpha-induced protein 6 (TNFAIP6) | This gene can be induced by tumor necrosis factor alpha and interleukin-1 | 1153 | 78.577 | 0.349 | 7.049e-90 |
| Calumenin (CALU) | A calcium-binding protein localized in the endoplasmic reticulum | 1166 | 80.102 | 0.348 | 1.922e-89 |
CORD analysis was done to find out probable co-regulated genes for vimentin from different micro-array experiments. A few selected co-expressed genes which are important in pro-inflammatory signalling are listed. Detailed data is given as supplementary material.